Cosmo Direct Supply Addresses Menopause Skin Research and Treatment Protocols

In advance of World Menopause Day on October 18, Galderma conducted a global survey with 5,090 women from the USA, UK, Brazil, and China. The survey revealed that 56% of respondents initially attributed menopause-related skin changes to aging, while only 29% recognized menopause as the cause. Additionally, half of the participants were unaware that hormonal changes in perimenopause and menopause could impact skin health.

These insights present a significant opportunity for aesthetic practitioners. Many patients may mistakenly link skin issues solely to aging instead of considering hormonal influences. Clinics that can clarify these issues and provide tailored treatment plans are likely to foster trust and long-term relationships with their patients.

Galderma has also released findings from an investigator-led trial, overseen by Dr. Andreas Nikolis, which treated the face and décolletage of menopausal women over eight months. Participants received Restylane Skinboosters and Sculptra in varying sequences. Those treated with Restylane Skinboosters first demonstrated a 27.3% increase in facial dermal thickness, compared to a 15.7% increase in the Sculptra-first group. Across both groups, 98% of patients reported natural-looking results, 96% would recommend the treatment, and 92% would opt for it again. The study emphasizes the importance of hydrating the skin before stimulating collagen production, aligning with the multi-product strategies many practitioners are adopting.

Cosmo Direct Supply provides both Sculptra and Restylane Skinboosters, facilitating this sequenced approach. Sculptra, known for collagen stimulation, promotes gradual enhancement in skin quality, while Restylane Skinboosters Vital Lidocaine, along with its lighter version, improves hydration and includes lidocaine for enhanced comfort. These products are available to licensed medical professionals at wholesale rates, accompanied by volume discounts and prompt shipping options.

The research underscores a growing need for clinics to engage in discussions about menopause and its skin effects. Daniel Pashai, CEO of Cosmo Direct Supply, stated that many clinics are just beginning to develop menopause-focused protocols and emphasized the importance of educating patients about these changes. Cosmo Direct Supply plans to continue monitoring clinical research in menopause-related skincare and updating their product offerings as required.

Cosmo Direct Supply offers a range of genuine, CE-certified aesthetic products to licensed medical professionals and clinics across the USA and worldwide, ensuring rapid shipping and dedicated support.